# Comparison of Premixed Insulins Aspart 30, Aspart 70 and Aspart on Postprandial Lipids

> **NCT01293396** · PHASE4 · COMPLETED · sponsor: **Medical University of Graz** · enrollment: 20 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** Insulin Aspart
- **DRUG:** Insulin Aspart 30
- **DRUG:** Insulin Aspart 70

## Key facts

- **NCT ID:** NCT01293396
- **Lead sponsor:** Medical University of Graz
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2011-02
- **Final completion:** 2011-03
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2021-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01293396

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01293396, "Comparison of Premixed Insulins Aspart 30, Aspart 70 and Aspart on Postprandial Lipids". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01293396. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*